99偷拍视频精品一区二区_伊人久久无码精品亚洲日韩_884AA四虎影成人精品一区_校花被带到密室吸乳憋尿漫画_亚洲色图制服诱惑_美女视频黄a视频全免费观看_最新更新中文字幕91_日韓亞洲歐美在線觀看

World's First! BRL Medicin's BCMA UCAR-T
Successfully Treats Neuromyelitis Optica Spectrum Disorder

MORE

The First Patient Treated with BRL Medicine’s
BRL-201 Therapy Achieves Over 5 Years of Cancer-Free Survival

MORE

World's first β0/β0 severe thalassemia patient cured for 5 years by BRL-101

MORE

BRL Medicine Awarded "First Prize of 2024 Shanghai Science and Technology Progress Award"

MORE

World's First! BRL Medicine's UCAR-T Successfully Treat Relapsed/Refractory Systemic Lupus Erythematosus

MORE

About BRL Medicine

At BRL Medicine Inc., we aim to become the world's leading Cellular & Gene pharmaceutical company in the era of new commercial civilization, with the mission of "Leading innovation with gene editing, developing breakthrough therapy and benefiting all mankind". With its independent R&D center and the "Shanghai Research Center for Gene Editing and Cell Therapy", jointly established by BRL Medicine and university, BRL Medicine has obtained more than 100 patent achievements, and initiated 19 Investigator-Initiated clinical Trials (IIT) in 20 leading hospitals in China, 6 projects having received IND approvals, with many pipeline projects have entered into IND application stage.

Learn More

Gene Therapy

World's first β0/β0 severe thalassemia
patient cured for 5 years by BRL-101

LEARN MORE

Cell Therapy

World's First! BRL Medicin's BCMA UCAR-T
Successfully Treats Neuromyelitis Optica Spectrum Disorder

LEARN MORE

Product Pipeline

Subscribe：Submit
Back to top